Researchers at the Johns Hopkins Malaria
Research Institute have, for the first time, determined the function of a
series proteins within the mosquito that transduce a signal that enables the
mosquito to fight off infection from the parasite that causes malaria in
humans.
Together,
these proteins are known as immune deficiency (Imd) pathway signal transducing
factors, are analogous to an electrical circuit. As each factor is switched on
or off it triggers or inhibits the next, finally leading to the launch of an
immune response against the malaria parasite. The study was published June 7 in
the journal PLoS Pathogens.
The
latest study builds upon earlier work of the research team, in which they found
that silencing one gene of this circuit, Caspar, activated Rel2, an Imd pathway
transcription factor of the Anopheles gambiae mosquito.
The
activation of Rel2 turns on the effectors TEP1, APL1 and FBN9 that kill
malaria-causing parasites in the mosquito's gut. More significantly, this study
discovered the Imd pathway signal transducing factors and effectors that will
mediate a successful reduction of parasite infection at their early ookinete
stage, as well as in the later oocyst stage when the levels of infection were
similar to those found in nature.
"Identifying
and understanding how all of the players work is crucial for manipulating the
Imd pathway as an invention to control malaria. We now know which genes can be
manipulated through genetic engineering to create a malaria resistant
mosquito" said George Dimopoulos PhD, professor in the Department of Molecular
Microbiology and Immunology at the Johns Hopkins Bloomberg School of
Public Health.
To
conduct the study, Dimopoulos's team used a RNA interference method
to "knock down" the genes of the Imd pathway. As the components were
inactivated, the researchers could observe how the mosquito's resistance toparasite infection would
change.
"Imagine
a string of Christmas lights or other circuit that will not work when parts
aren't aligned in the right sequence. That is how we are working with the
mosquito's immune system," explained Dimopolous. "We manipulate the
molecular components of the mosquito's immune system to identify the parts
necessary to kill the malaria parasites."
Malaria
kills more than 800,000 people worldwide each year. Many are children.
More
information: "Anopheles
Imd pathway factors and effectors in infection intensity-dependent
anti-Plasmodium action", PLoS Pathogens.
No comments:
Post a Comment